Equities

Marksans Pharma Ltd

MARKSANS:NSI

Marksans Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)300.50
  • Today's Change11.50 / 3.98%
  • Shares traded6.81m
  • 1 Year change+116.65%
  • Beta1.3135
Data delayed at least 15 minutes, as of Nov 12 2024 10:28 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue21,77418,52114,908
OPERATING EXPENSES
Cost of revenue total10,9429,2147,480
Selling, general and admin. expenses, total5,4044,5414,541
Depreciation/amortization743519448
Unusual expense(income)165----
Other operating expenses, total6371,263298
Total operating expense17,89115,53612,767
Operating income3,8832,9852,141
Other, net04570
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes4,2353,3772,475
Provision for income taxes1,086723607
Net income after taxes3,1492,6531,868
Minority interest(12)9.87(22)
Net income before extra. Items3,1372,6631,846
Total extraordinary items------
Net income3,1372,6631,846
Inc.avail. to common excl. extra. Items3,1372,6631,846
Inc.avail. to common incl. extra. Items3,1372,6631,846
EPS RECONCILIATION
Basic/primary weighted average shares453415409
Basic/primary eps excl. extra items6.926.414.51
Basic/primary eps incl. extra items6.926.414.51
Dilution adjustment------
Diluted weighted average shares453415409
Diluted eps excl. extra items6.926.414.51
Diluted eps incl. extra items6.926.414.51
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.600.500.25
Gross dividend - common stock227227106
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1125754
SUPPLEMENTAL INCOME
Depreciation, supplemental620414407
Total special items1642.640
NORMALISED INCOME
Normalized income before taxes4,3993,3792,475
Effect of special items on income taxes420.570
Income tax excluding impact of special items1,128724607
Normalized income after tax3,2712,6551,868
Normalized income avail. to common3,2592,6651,846
Basic normalized EPS7.196.424.51
Diluted normalized EPS7.196.424.51
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.